Advanced Clinical, a leading provider of clinical research services, announces its "One Team" approach.

Advanced Clinical, a leading provider of clinical research services, announces its "One Team" approach.
Bannockburn, IL (Vocus) October 12, 2010

Advanced Clinical, a leading provider of clinical research services, announces its "One Team" approach.

"One Team" is Advanced Clinical's approach for partnering with clients to work collaboratively towards their clinical trial goals. The "One Team" model has five key characteristics:

 

  • Single point of contact from Advanced Clinical ensures transparency and accessibility
  • Team construction aligns all cross-functional resources necessary for a clinical trial, including client personnel, subject matter experts, and/or third party partners
  • Engagement involves an ongoing, two-way communication plan to enable continuous open dialogue
  • Collaboration creates the optimal teamwork-based solution
  • Strategic joint investment uses creative commercial models

The "One Team" model is the foundation of Advanced Clinical's marketing and program management, and it is one of the elements in Advanced Clinical's Industry Leading R&D Performance (ILRDP) framework. ILRDP contains many components, including known risks for every part of a clinical trial, associated mitigation techniques, and leading practices within and outside of the life sciences industry.

 

"Advanced Clinical implements our teaming model to ensure we get speed to results for the client," said Leo Sheridan, CEO of Advanced Clinical.

About Advanced Clinical: Advanced Clinical provides consulting services, strategic sourcing (CRO), talent management, and technology solutions to the Life Sciences industry. With 15+ years of experience, Advanced Clinical is an established presence in the clinical research field, providing services specifically for Pharmaceutical, Biopharmaceutical, Biotechnology and Medical Device organizations. Advanced utilizes a value-based, "One Team" approach. To learn more, visit http://www.advancedclinical.com.

Contact:
Rosemarie Truman
rtruman(at)advancedclinical(dot)com
1200 Lakeside Drive
Bannockburn, IL 60015
Ph: 202-438-2208

Suggested Articles

Outgoing BIO Chair John Maraganore and his successor, Jeremy Levin, reflected on drug pricing, its drivers and its place in the innovation ecosystem.

The study is assessing the effect of the oral AXL inhibitor when given to elderly AML patients in combination with low-intensity chemotherapy.

The proportion of patients who had a greater than 1 g/dL increase in hemoglobin is down on GBT’s prior update but still superior to placebo.